{"meta":{"query_hash":"105da624c62d","filters":{"venue":"Nature Clinical Practice Oncology"},"cohort_total":20,"direct_labels_cover":1,"predictions_cover":20,"exported":20,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/105da624c62d","api":"https://metacan.xera.ac/api/v1/cohort?venue=Nature+Clinical+Practice+Oncology"},"results":[{"id":"W1964593378","doi":"10.1038/ncponc0425","title":"Are prostate cancer clinical trial enrollment criteria and endpoints appropriate?","year":2006,"lang":"en","type":"article","venue":"Nature Clinical Practice Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Prostate cancer; Medicine; Cancer; Prostate; Clinical trial; Oncology; Medical physics; Internal medicine","score_opus":0.11155385858593407,"score_gpt":0.5612569716889142,"score_spread":0.4497031131029801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964593378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84685814,0.01929647,0.0000093811705,0.10191779,0.006848838,0.0036901513,0.00006535993,0.00013709476,0.021176776],"genre_scores_gemma":[0.95008785,0.012176609,0.005192721,0.015811818,0.008851311,0.0004212102,0.00010546038,0.00007433814,0.007278709],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.99482036,0.0014820942,0.0015878209,0.000971047,0.00054348836,0.00059521507],"domain_scores_gemma":[0.99238986,0.005087135,0.0010393835,0.00046203096,0.00057874905,0.00044282642],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0047789803,0.0002995339,0.0011934718,0.000103571634,0.00016455943,0.000059362595,0.0001566907,0.0016576089,0.00031696405],"category_scores_gemma":[0.010461841,0.00021140653,0.00028724642,0.00022640347,0.00067490933,0.00025453468,0.00019890458,0.0037207375,0.000077695244],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4885797,0.012059605,0.09153347,0.00019125678,0.0009713724,0.0037352422,0.000100909005,7.358096e-7,0.00017737299,0.000575172,0.13362354,0.26845166],"study_design_scores_gemma":[0.12894526,0.007324455,0.13662887,0.000092293034,0.0007297335,0.00015685057,0.00022965462,0.000040518138,0.00007238174,0.0009923215,0.72453845,0.00024923115],"about_ca_topic_score_codex":0.00010214105,"about_ca_topic_score_gemma":0.00010496388,"teacher_disagreement_score":0.5909149,"about_ca_system_score_codex":0.00030596938,"about_ca_system_score_gemma":0.0010872912,"threshold_uncertainty_score":0.99963844},"labels":[],"label_agreement":null},{"id":"W1969340153","doi":"10.1038/ncponc0966","title":"Active surveillance for favorable-risk prostate cancer: who, how and why?","year":2007,"lang":"en","type":"review","venue":"Nature Clinical Practice Oncology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; University of Toronto","funders":"","keywords":"Medicine; Prostate cancer; Disease; Intervention (counseling); Cancer; Intensive care medicine; Comorbidity; Prostate cancer screening; Internal medicine; Prostate-specific antigen; Psychiatry","score_opus":0.10525061861848292,"score_gpt":0.5326373297310226,"score_spread":0.4273867111125397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969340153","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000013850461,0.9696837,0.000033292017,0.018237954,0.002574224,0.0060258703,0.0012768101,0.00006981827,0.0020844503],"genre_scores_gemma":[0.00002432428,0.984027,0.00388478,0.006752795,0.002250644,0.00158207,0.00043004603,0.00013349381,0.0009147912],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946928,0.0012233425,0.0014685934,0.0014956453,0.0003675133,0.0007520767],"domain_scores_gemma":[0.9561901,0.03873051,0.002980075,0.00063659216,0.00093703356,0.0005256816],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0041927453,0.00073973247,0.0048272414,0.00017629964,0.0002063431,0.000065351,0.00020734358,0.0035817109,0.000030278085],"category_scores_gemma":[0.025794074,0.00052548456,0.0008304066,0.0003995948,0.00041774832,0.00026219332,0.00014643549,0.005614035,0.0000135260325],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020669962,0.0009331925,0.0005328774,0.0056931092,0.0021912945,0.00036278326,0.00003877717,9.175004e-8,2.5796187e-8,0.00014256829,0.054368384,0.9336699],"study_design_scores_gemma":[0.004253195,0.0049740747,0.00038535486,0.004115636,0.007355086,0.00030283292,0.000076846285,0.0000033906776,8.448155e-7,0.000078042984,0.9780055,0.0004491711],"about_ca_topic_score_codex":0.00009243334,"about_ca_topic_score_gemma":0.00033334212,"teacher_disagreement_score":0.93322074,"about_ca_system_score_codex":0.0012050421,"about_ca_system_score_gemma":0.0032327673,"threshold_uncertainty_score":0.9997197},"labels":[],"label_agreement":null},{"id":"W1972792407","doi":"10.1038/ncponc0822","title":"Surgery Insight: radical vaginal trachelectomy as a method of fertility preservation for cervical cancer","year":2007,"lang":"en","type":"review","venue":"Nature Clinical Practice Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Trachelectomy; Medicine; Cervical cancer; Fertility preservation; Fertility; Lymphadenectomy; Radical surgery; Surgery; Cervix; Radical Hysterectomy; Cancer; Population; Internal medicine","score_opus":0.27121106661041133,"score_gpt":0.6034713355973509,"score_spread":0.33226026898693956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972792407","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000022169668,0.9821086,0.0011217811,0.0054123546,0.0024799805,0.0031674453,0.00011280468,0.000063343396,0.005511508],"genre_scores_gemma":[0.00008047895,0.9621127,0.027562357,0.005783229,0.002865609,0.0006555708,0.00046387158,0.000093609335,0.00038257395],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99065375,0.0028655822,0.0036388838,0.0012647161,0.0009047629,0.00067227584],"domain_scores_gemma":[0.8941491,0.100755736,0.0024893784,0.0007066401,0.0012601984,0.000638919],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.009162325,0.00063794234,0.006610593,0.00045576465,0.00009297311,0.00001654072,0.0003698763,0.00623436,0.00065266545],"category_scores_gemma":[0.08223829,0.00044712017,0.0025071406,0.0015222128,0.00034712255,0.00027859322,0.00013216498,0.0060129967,0.000031608957],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012115948,0.004112312,0.00017618951,0.011625154,0.0021652505,0.00020623543,0.000017550848,6.1088386e-8,6.445041e-7,0.00041639648,0.0028338868,0.96633035],"study_design_scores_gemma":[0.0042509506,0.0029936691,0.0010700272,0.0021268406,0.013264383,0.0003099824,0.000009687223,0.0000066426937,0.0000078527555,0.0003730414,0.975263,0.0003239265],"about_ca_topic_score_codex":0.0002632055,"about_ca_topic_score_gemma":0.00007561624,"teacher_disagreement_score":0.9724291,"about_ca_system_score_codex":0.0010053194,"about_ca_system_score_gemma":0.006925648,"threshold_uncertainty_score":0.99979806},"labels":[],"label_agreement":null},{"id":"W1972959587","doi":"10.1038/ncponc1089","title":"Mechanisms of Disease: epithelial–mesenchymal transition—does cellular plasticity fuel neoplastic progression?","year":2008,"lang":"en","type":"article","venue":"Nature Clinical Practice Oncology","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":258,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"National Cancer Institute","keywords":"Epithelial–mesenchymal transition; Biology; Metastasis; Mesenchymal stem cell; Phenotype; Morphogenesis; Tumor progression; Cancer research; Cancer; Cell biology; Genetics; Gene","score_opus":0.03127721051069335,"score_gpt":0.40759543672073933,"score_spread":0.37631822621004596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972959587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72243005,0.020632684,0.08290666,0.12113898,0.020496888,0.0055922447,0.00084480055,0.00058585097,0.02537186],"genre_scores_gemma":[0.96422595,0.001712246,0.02798024,0.004710577,0.00093694916,0.00003634579,0.000047435293,0.000037315047,0.0003129601],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99660164,0.00062549324,0.0010805185,0.0006224015,0.00067663955,0.0003933006],"domain_scores_gemma":[0.9919553,0.0058046454,0.000644094,0.00038111853,0.00057860976,0.00063622807],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.001094643,0.00026304473,0.0009868514,0.00011318232,0.00013939173,0.000006607543,0.00016730739,0.00089320977,0.00066987384],"category_scores_gemma":[0.01092834,0.00018089199,0.00042862247,0.00029442733,0.00056673127,0.00019796872,0.00007009262,0.0021927783,0.00006407623],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24017556,0.08835812,0.006694343,0.0060756924,0.0060807555,0.044912353,0.0035025382,0.00029865958,0.19224137,0.04743703,0.062173486,0.30205008],"study_design_scores_gemma":[0.021268543,0.016896557,0.03711256,0.0006003371,0.008301147,0.0015454241,0.0009544881,0.0006998376,0.017094748,0.0067459038,0.88773626,0.0010442138],"about_ca_topic_score_codex":0.000016985028,"about_ca_topic_score_gemma":0.000015724027,"teacher_disagreement_score":0.8255628,"about_ca_system_score_codex":0.00010440933,"about_ca_system_score_gemma":0.0015519232,"threshold_uncertainty_score":0.997403},"labels":[],"label_agreement":null},{"id":"W1981235693","doi":"10.1038/ncponc1244","title":"Prophylactic and therapeutic anticoagulation for thrombosis—major issues in oncology","year":2008,"lang":"en","type":"review","venue":"Nature Clinical Practice Oncology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Ottawa","funders":"","keywords":"Medicine; Thrombosis; Venous thromboembolism; Intensive care medicine; Low molecular weight heparin; Cancer; Heparin; Quality of life (healthcare); Anticoagulant; Population; Anticoagulant therapy; Surgery; Internal medicine","score_opus":0.15547004364565145,"score_gpt":0.5607560632053816,"score_spread":0.4052860195597302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981235693","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006383333,0.9731969,0.000024656103,0.014009275,0.0019230902,0.0057578525,0.000009586649,0.000063458196,0.004951311],"genre_scores_gemma":[0.0008518012,0.98098046,0.0076090884,0.007867586,0.0016632818,0.0006147359,0.00010609479,0.00010843574,0.00019853296],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99421185,0.0016709589,0.002075624,0.0011460667,0.000333001,0.0005624983],"domain_scores_gemma":[0.98189914,0.015317474,0.0016153023,0.0006036946,0.00033841468,0.00022597879],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.002613294,0.0005696383,0.005729701,0.0003842458,0.0001452895,0.000030190997,0.00024563997,0.0042828987,0.000046164958],"category_scores_gemma":[0.011346213,0.00043540684,0.00064599694,0.00041336162,0.00039984536,0.00018080622,0.00017653777,0.0039461497,0.000066663786],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033927907,0.0049177418,0.00006111983,0.007190304,0.000862261,0.00028608768,0.00011145623,2.0987183e-7,4.9094723e-7,0.0024436542,0.006363413,0.97742397],"study_design_scores_gemma":[0.0027788924,0.0064381496,0.0018857867,0.0014170776,0.007347454,0.00058657187,0.000121045865,0.000017720115,1.779705e-7,0.0003263696,0.9787082,0.00037255156],"about_ca_topic_score_codex":0.00004982424,"about_ca_topic_score_gemma":0.000073183095,"teacher_disagreement_score":0.97705144,"about_ca_system_score_codex":0.0006554772,"about_ca_system_score_gemma":0.001824407,"threshold_uncertainty_score":0.9998098},"labels":[],"label_agreement":null},{"id":"W1981709329","doi":"10.1038/ncponc0477","title":"What is the risk of cardiac morbidity with adjuvant radiotherapy for breast cancer?","year":2006,"lang":"en","type":"article","venue":"Nature Clinical Practice Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Breast cancer; Radiation therapy; Adjuvant; Oncology; Adjuvant radiotherapy; Internal medicine; MEDLINE; Cancer","score_opus":0.015411325685063168,"score_gpt":0.397542310260558,"score_spread":0.3821309845754948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981709329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4723615,0.31478238,0.00086298794,0.19547927,0.008226376,0.0028588632,0.0028678419,0.000051600513,0.0025091714],"genre_scores_gemma":[0.9017041,0.079144195,0.0063773035,0.008195107,0.003921892,0.00027354737,0.000072184775,0.000050183895,0.00026152618],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982117,0.00048603813,0.00040616168,0.00048144374,0.00016617014,0.00024847785],"domain_scores_gemma":[0.99630696,0.0020301621,0.0006518648,0.00047455236,0.0004867965,0.000049695725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094828696,0.00019912263,0.00048662833,0.000015790645,0.00014533964,0.000018052171,0.00021908215,0.00062515977,0.00001718422],"category_scores_gemma":[0.0004854365,0.00011777228,0.0002758808,0.00009609177,0.00044497635,0.00002137192,0.00006221659,0.0005682274,0.000001320659],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021784749,0.0027274638,0.16130994,0.00006485167,0.0070485976,0.000014176298,0.00022091897,0.00015357975,0.003421478,0.0006014513,0.21963216,0.5830206],"study_design_scores_gemma":[0.002238609,0.0011841275,0.2716516,0.000020081252,0.0009108566,0.000049259743,0.00036174446,0.000013477744,0.0016909714,0.0001263368,0.7215784,0.00017449178],"about_ca_topic_score_codex":0.0005815392,"about_ca_topic_score_gemma":0.00065359083,"teacher_disagreement_score":0.58284616,"about_ca_system_score_codex":0.00007448876,"about_ca_system_score_gemma":0.00036560424,"threshold_uncertainty_score":0.48218048},"labels":[],"label_agreement":null},{"id":"W1994831541","doi":"10.1038/ncponc0286","title":"Clinical practice guidelines and healthcare decisions: credibility gaps and unfulfilled promises?","year":2005,"lang":"en","type":"review","venue":"Nature Clinical Practice Oncology","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; University of Calgary","funders":"","keywords":"Credibility; Health care; Clinical Practice; Business; Public relations; Political science; Internet privacy; Medicine; Nursing; Computer science; Law","score_opus":0.5754389600370696,"score_gpt":0.7055001616580581,"score_spread":0.13006120162098844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994831541","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003734923,0.8111644,0.000107436565,0.17613521,0.004271355,0.005545244,0.00012448117,0.00020122035,0.0024133034],"genre_scores_gemma":[0.000011602679,0.681215,0.23408528,0.075280234,0.008399354,0.00018681207,0.00041513584,0.0001668623,0.00023976676],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.95709026,0.01529167,0.020526923,0.004122138,0.0017964904,0.0011724894],"domain_scores_gemma":[0.5092133,0.45662487,0.015569145,0.0035064712,0.012125388,0.002960802],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["metaresearch","metaepi_narrow","research_integrity"],"category_scores_codex":[0.06682037,0.001438291,0.00919581,0.0004382852,0.00044893156,0.00018931976,0.000675961,0.010389292,0.00025048733],"category_scores_gemma":[0.8946544,0.0011137874,0.0016462902,0.00097500754,0.0014347935,0.0017177538,0.0013815277,0.020708254,0.00027909328],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036297198,0.002943516,0.00017981643,0.0026299525,0.0012330901,0.00079794676,0.000023107748,9.814932e-8,5.626842e-8,0.00040957105,0.10019747,0.88795567],"study_design_scores_gemma":[0.0070095807,0.0055658226,0.0004907598,0.0055033355,0.018949045,0.0087794885,0.0006517513,0.00005717541,2.0163172e-8,0.0003222685,0.95182556,0.00084519567],"about_ca_topic_score_codex":0.00015212467,"about_ca_topic_score_gemma":0.0002624385,"teacher_disagreement_score":0.8871105,"about_ca_system_score_codex":0.00077108183,"about_ca_system_score_gemma":0.010970038,"threshold_uncertainty_score":0.9998367},"labels":[],"label_agreement":null},{"id":"W1995142725","doi":"10.1038/ncponc0965","title":"Book review: Abrahm JL (2005) A Physician's Guide to Pain and Symptom Management in Cancer Patients, edn 2. Baltimore: The Johns Hopkins University Press","year":2007,"lang":"en","type":"article","venue":"Nature Clinical Practice Oncology","topic":"Complementary and Alternative Medicine Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Gerontology; Medicine; Pain management; Family medicine; Physical therapy","score_opus":0.02643879993555653,"score_gpt":0.4435070043994754,"score_spread":0.41706820446391885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995142725","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014118852,0.22066388,0.0008015725,0.50199676,0.0038226082,0.0078097377,0.00006967107,0.00010481246,0.25061208],"genre_scores_gemma":[0.010050183,0.41654143,0.0019384602,0.5672605,0.0013606851,0.00003098526,0.0000307851,0.000021936408,0.0027650578],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99726397,0.00084261387,0.0006442991,0.0004868807,0.00034823467,0.0004140155],"domain_scores_gemma":[0.99247044,0.0064215,0.0003412923,0.00030908303,0.0002517665,0.0002058975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047933096,0.00019903672,0.00059790356,0.00013319647,0.00012840149,0.000005082827,0.00021362909,0.00010170247,0.000120449426],"category_scores_gemma":[0.0046455683,0.00013862355,0.00009325601,0.00035916653,0.00022065,0.00015314374,0.0003538975,0.0014071092,0.000007550866],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009709916,0.0009997234,0.008409189,0.00016077542,0.00033240378,0.0004143121,0.00012612568,6.749617e-7,6.171495e-7,0.00038576848,0.71034324,0.2778562],"study_design_scores_gemma":[0.0028365809,0.0017080177,0.109912574,0.00053600554,0.0005786164,0.000006025925,0.0005754207,0.0000098732335,0.0000016909605,0.0000028324046,0.88371414,0.000118227894],"about_ca_topic_score_codex":0.0004863176,"about_ca_topic_score_gemma":0.0010069598,"teacher_disagreement_score":0.27773798,"about_ca_system_score_codex":0.00038404446,"about_ca_system_score_gemma":0.00010650483,"threshold_uncertainty_score":0.61132675},"labels":[],"label_agreement":null},{"id":"W1999742139","doi":"10.1038/ncponc0248","title":"Serrated adenoma of the colorectum and the DNA-methylator phenotype","year":2005,"lang":"en","type":"review","venue":"Nature Clinical Practice Oncology","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":192,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Hyperplastic Polyp; Adenoma; Colorectal cancer; Pathology; Lesion; Biology; DNA methylation; Cancer research; Cancer; Medicine; Internal medicine; Genetics; Colonoscopy; Gene","score_opus":0.06987392463734961,"score_gpt":0.4890681184722635,"score_spread":0.4191941938349139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999742139","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010598371,0.96990496,0.000005151733,0.009335687,0.0031720977,0.0016932695,0.0000109462135,0.0000477942,0.015724128],"genre_scores_gemma":[0.0020738342,0.99001205,0.000673171,0.0041314885,0.0022047681,0.00008613421,0.00001155887,0.00004807495,0.00075894746],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99394155,0.0033961532,0.0014375999,0.0005738104,0.0003874456,0.00026341985],"domain_scores_gemma":[0.9746254,0.022029322,0.0020338814,0.000701557,0.00046202532,0.00014779244],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0045119845,0.00035393404,0.00269293,0.000084260646,0.00016560884,0.000018649935,0.0003519857,0.0031316748,0.000078411365],"category_scores_gemma":[0.03812418,0.00016678374,0.0008131749,0.00071397773,0.0010235133,0.00008039322,0.00026288492,0.0075799674,0.000027558024],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00808476,0.00023167006,0.0000063809107,0.00084459287,0.0006226325,0.000019696568,0.00004737286,1.4462627e-7,3.7615337e-7,0.00037378207,0.005597856,0.98417073],"study_design_scores_gemma":[0.0025388831,0.002959947,0.00027353916,0.00111179,0.006627308,0.0008311376,0.00005739608,0.000019297748,0.0000010974029,0.000055274537,0.9853703,0.00015402566],"about_ca_topic_score_codex":0.00003812324,"about_ca_topic_score_gemma":0.00010726569,"teacher_disagreement_score":0.9840167,"about_ca_system_score_codex":0.00025727123,"about_ca_system_score_gemma":0.0020795634,"threshold_uncertainty_score":0.99816245},"labels":[],"label_agreement":null},{"id":"W2002763378","doi":"10.1038/ncponc0427","title":"Should women with early hormone-responsive breast cancer be switched from tamoxifen to anastrozole?","year":2006,"lang":"en","type":"article","venue":"Nature Clinical Practice Oncology","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Anastrozole; Tamoxifen; Breast cancer; Internal medicine; Oncology; Medicine; Cancer","score_opus":0.013718537269550074,"score_gpt":0.37174300740487043,"score_spread":0.35802447013532035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002763378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96783036,0.0027741715,0.00012557136,0.024782851,0.0005805316,0.0004948275,0.00016287023,0.000042154483,0.0032066342],"genre_scores_gemma":[0.9757343,0.0003493605,0.00421923,0.016798086,0.0020567903,0.00012671037,0.00012223673,0.00006202816,0.00053125084],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99688286,0.00069760997,0.0005776406,0.00088941766,0.0003230103,0.0006294507],"domain_scores_gemma":[0.99716115,0.0010281798,0.00040370692,0.00055737904,0.00043289765,0.00041667506],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00088380266,0.00034459945,0.00054093986,0.00006729442,0.00012792632,0.00004393608,0.00038000368,0.00219528,0.000055116496],"category_scores_gemma":[0.0012932409,0.00026828636,0.00013280609,0.000271184,0.00022327196,0.000027027552,0.00020237672,0.0020769273,0.000058664464],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1028861,0.0033176742,0.018473348,0.0000143856805,0.0024689685,0.0013257817,0.00032955653,0.00038532136,0.6123776,0.00044475653,0.2054239,0.05255264],"study_design_scores_gemma":[0.0051871543,0.009399973,0.25307894,0.000023548648,0.00039813895,0.0002532118,0.00035730895,0.000014499807,0.0065948754,0.00011059187,0.72389895,0.00068281597],"about_ca_topic_score_codex":0.00076383917,"about_ca_topic_score_gemma":0.00026954967,"teacher_disagreement_score":0.6057827,"about_ca_system_score_codex":0.0001497832,"about_ca_system_score_gemma":0.0008042454,"threshold_uncertainty_score":0.99997693},"labels":[],"label_agreement":null},{"id":"W2004805159","doi":"10.1038/ncponc0773","title":"Hereditary leiomyomatosis and renal cell cancer: an unusual and aggressive form of hereditary renal carcinoma","year":2007,"lang":"en","type":"article","venue":"Nature Clinical Practice Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Nephrectomy; Renal cell carcinoma; Debulking; Leiomyomatosis; Pathology; Radiology; Cancer; Internal medicine; Kidney","score_opus":0.03708986281287093,"score_gpt":0.4181664397243733,"score_spread":0.3810765769115024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004805159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9557685,0.029294463,0.000024207644,0.0046008066,0.0009711667,0.00062350795,0.000041228344,0.000041368432,0.008634752],"genre_scores_gemma":[0.98025256,0.0017160391,0.012861745,0.0028910753,0.001970621,0.00002098208,0.00006782416,0.000047330497,0.00017179272],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9964257,0.0004615702,0.0012314846,0.00081918924,0.00053451717,0.0005275269],"domain_scores_gemma":[0.991051,0.005949037,0.0012135078,0.00048459857,0.0005499044,0.0007519415],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0023845462,0.00036084664,0.0010997339,0.00019594606,0.00012656667,0.000013019904,0.0001577431,0.0015707399,0.000057725752],"category_scores_gemma":[0.002548156,0.00028887528,0.00017874305,0.00025179528,0.0007114502,0.00043831576,0.00018810015,0.0024329938,0.0000049880164],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0402336,0.008343963,0.2387253,0.00079751783,0.0015685146,0.063739344,0.0017803684,0.000002616624,0.011288409,0.0005545829,0.030868283,0.6020975],"study_design_scores_gemma":[0.015855398,0.031822193,0.8499345,0.0003107447,0.00369857,0.01666166,0.0028850767,0.00014387735,0.017324224,0.00054293935,0.060155265,0.00066555344],"about_ca_topic_score_codex":0.00045937134,"about_ca_topic_score_gemma":0.00040871135,"teacher_disagreement_score":0.6112092,"about_ca_system_score_codex":0.00027426425,"about_ca_system_score_gemma":0.0007961857,"threshold_uncertainty_score":0.9999563},"labels":[],"label_agreement":null},{"id":"W2013202228","doi":"10.1038/ncponc1294","title":"A case of prolonged disease-free survival in a patient with choroidal metastasis from breast cancer","year":2008,"lang":"en","type":"article","venue":"Nature Clinical Practice Oncology","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Lumpectomy; Radiation therapy; Breast cancer; Radiology; Axillary Lymph Node Dissection; Metastasis; Surgery; Male breast cancer; Cancer; Mastectomy; Internal medicine; Sentinel lymph node","score_opus":0.04483560855045114,"score_gpt":0.4206984550907654,"score_spread":0.37586284654031427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013202228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9741566,0.0033905993,0.0000063987277,0.018934663,0.00058450765,0.00081109785,0.0003899519,0.000027942813,0.0016982099],"genre_scores_gemma":[0.98973054,0.0005019851,0.0061330027,0.0031266504,0.00027392525,0.000108983266,0.00005842895,0.000026741287,0.00003971763],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99687594,0.0011599318,0.0007590445,0.00057182234,0.00032794388,0.00030528734],"domain_scores_gemma":[0.9938958,0.0041801217,0.00057103625,0.00060510135,0.00040085134,0.0003470777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071001454,0.0002263324,0.0009870105,0.00009996754,0.00008045839,0.000002736318,0.00013115462,0.0008263674,0.00020330067],"category_scores_gemma":[0.0056675794,0.00015972233,0.00017857981,0.00030452694,0.0004881199,0.0001860617,0.000107828324,0.0020800936,0.000014012514],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049105186,0.01232513,0.5532362,0.000033688615,0.0017099256,0.332969,0.00034915478,0.0000072173098,0.000017661514,0.00008841446,0.0012517858,0.04890664],"study_design_scores_gemma":[0.02736835,0.007961334,0.89469683,0.00010974406,0.0040035183,0.041072175,0.0005239837,0.00005638405,0.00003146248,0.00017118418,0.023712575,0.00029247673],"about_ca_topic_score_codex":0.0010394695,"about_ca_topic_score_gemma":0.0032154906,"teacher_disagreement_score":0.34146062,"about_ca_system_score_codex":0.00024769752,"about_ca_system_score_gemma":0.0016054079,"threshold_uncertainty_score":0.9037087},"labels":[],"label_agreement":null},{"id":"W2017777108","doi":"10.1038/ncponc1187","title":"Strategies for discovering novel cancer biomarkers through utilization of emerging technologies","year":2008,"lang":"en","type":"review","venue":"Nature Clinical Practice Oncology","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":786,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Biomarker discovery; Identification (biology); Data science; Computer science; Computational biology; Emerging technologies; Biomarker; Cancer biomarkers; Cancer; Bioinformatics; Risk analysis (engineering); Biology; Medicine; Proteomics; Artificial intelligence; Gene","score_opus":0.1882171952969201,"score_gpt":0.5661340406730772,"score_spread":0.37791684537615705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017777108","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000012530645,0.91598964,0.07342484,0.0007653827,0.00029432785,0.0008657824,0.00036392908,0.0002821825,0.008012671],"genre_scores_gemma":[0.000022257896,0.796461,0.20181347,0.00008436824,0.0002354527,0.0010887115,0.00018111336,0.00006254193,0.000051060604],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971763,0.00005961478,0.0015674738,0.0007239877,0.00016511136,0.0003075132],"domain_scores_gemma":[0.99040645,0.005780123,0.0028172398,0.0006419617,0.00031987153,0.00003433703],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00037653052,0.00039491706,0.0017052746,0.00007548061,0.00015794714,0.000020070496,0.00063516333,0.0036060647,0.000024594485],"category_scores_gemma":[0.0046729194,0.00033626435,0.0006029873,0.0003657392,0.00045447564,0.00043336555,0.00023863498,0.0025141202,0.0000014711926],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007571299,0.00034902606,0.0000010450228,0.0042478596,0.00039407169,0.000003949806,0.000021577835,0.0000068516383,0.00006553638,0.025587536,0.00197651,0.9672703],"study_design_scores_gemma":[0.00030732478,0.00009027847,7.90223e-8,0.0018493936,0.00071595144,0.00005789173,0.000686914,0.00003208688,0.00014983967,0.0029613806,0.9928365,0.0003123552],"about_ca_topic_score_codex":0.00003194189,"about_ca_topic_score_gemma":0.000018768698,"teacher_disagreement_score":0.99086,"about_ca_system_score_codex":0.00027620685,"about_ca_system_score_gemma":0.0013384547,"threshold_uncertainty_score":0.9999089},"labels":[],"label_agreement":null},{"id":"W2025822934","doi":"10.1038/ncponc0736","title":"Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress","year":2007,"lang":"en","type":"review","venue":"Nature Clinical Practice Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":450,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jennerex Biotherapeutics (Canada)","funders":"","keywords":"Oncolytic virus; Virotherapy; Clinical trial; Third generation; Genetically engineered; First generation; Medicine; Cancer; Virology; Virus; Biology; Computer science; Internal medicine; Gene; Genetics","score_opus":0.13672145565291424,"score_gpt":0.5712438850854086,"score_spread":0.4345224294324943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025822934","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014355629,0.98815316,0.000020607617,0.0004302695,0.0013705607,0.0055041374,0.00016185857,0.000022223137,0.002901609],"genre_scores_gemma":[0.00028200116,0.98704296,0.0076881833,0.00072000263,0.0032458063,0.00024010862,0.0003491161,0.00017124087,0.00026057236],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98404324,0.006917935,0.0055129016,0.0017683946,0.00097104255,0.0007864943],"domain_scores_gemma":[0.98062,0.009685221,0.006049223,0.0019486072,0.0012435551,0.00045334612],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.01802399,0.00075250166,0.004499401,0.00028567945,0.00007211788,0.00001965727,0.0014732007,0.00816509,0.000030777584],"category_scores_gemma":[0.021511253,0.00054009334,0.0016560762,0.000749146,0.0020249065,0.00001664594,0.0003835579,0.006246582,0.00001880379],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.33971867,0.004179251,0.000010035665,0.0011899224,0.0016493524,0.000106772444,0.000010386797,2.1569154e-7,0.0000143038515,0.000021569931,0.0016940328,0.6514055],"study_design_scores_gemma":[0.04115003,0.095940575,0.000009379321,0.0013563142,0.0014065442,0.00012683583,0.000028415821,9.4261577e-7,0.000075634394,0.000007569372,0.8594567,0.00044104393],"about_ca_topic_score_codex":0.00000678114,"about_ca_topic_score_gemma":0.00010615887,"teacher_disagreement_score":0.8577627,"about_ca_system_score_codex":0.00014293875,"about_ca_system_score_gemma":0.008483452,"threshold_uncertainty_score":0.9997051},"labels":[],"label_agreement":null},{"id":"W2037335759","doi":"10.1038/ncponc0192","title":"Duration of adjuvant therapy for colorectal cancer: are we overtreating our patients?","year":2005,"lang":"en","type":"article","venue":"Nature Clinical Practice Oncology","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Colorectal cancer; Medicine; Duration (music); Adjuvant therapy; Adjuvant; Oncology; Cancer; Internal medicine; Art","score_opus":0.06562537316319698,"score_gpt":0.4935127252650818,"score_spread":0.4278873521018848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037335759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9140442,0.007109318,0.000030221034,0.068460844,0.0018304142,0.0021230339,0.00008960368,0.00007145057,0.0062409155],"genre_scores_gemma":[0.9814482,0.00445021,0.0069486857,0.0051404973,0.0014454778,0.0002605447,0.00006335451,0.00003463538,0.00020840832],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974505,0.0003469938,0.0010431389,0.0004940211,0.00036242834,0.00030296893],"domain_scores_gemma":[0.9924102,0.0049636927,0.0012549093,0.00021737767,0.00096553704,0.0001883005],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0008369833,0.00021932037,0.00090924837,0.00006957892,0.000086841465,0.00000874783,0.00010992344,0.00096863956,0.00009662126],"category_scores_gemma":[0.010002058,0.00016754294,0.00033311747,0.0002212181,0.00008154906,0.00026034433,0.000046864818,0.0010937325,0.000013046521],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032057043,0.0065749194,0.21001735,0.00005825998,0.0006099345,0.00004018816,0.00015022689,0.000013976845,0.0003754015,0.00015140018,0.013404801,0.7365465],"study_design_scores_gemma":[0.019788358,0.014301439,0.3592493,0.00013305599,0.00057153846,0.00003878951,0.00036995055,0.00047713317,0.0016369674,0.00007618251,0.6031362,0.00022108624],"about_ca_topic_score_codex":0.000032941127,"about_ca_topic_score_gemma":0.00019337129,"teacher_disagreement_score":0.7363254,"about_ca_system_score_codex":0.00059992686,"about_ca_system_score_gemma":0.00056160503,"threshold_uncertainty_score":0.9983371},"labels":[],"label_agreement":null},{"id":"W2057380776","doi":"10.1038/ncponc0482","title":"Hyperplastic polyposis and cancer of the colon with gastrinoma of the duodenum","year":2006,"lang":"en","type":"article","venue":"Nature Clinical Practice Oncology","topic":"Metastasis and carcinoma case studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Gastrinoma; Gastroenterology; Colonoscopy; Nausea; Duodenum; Internal medicine; Vomiting; Abdominal pain; Colorectal cancer; Cancer; Gastrin","score_opus":0.022260971587757104,"score_gpt":0.393228904697178,"score_spread":0.37096793310942094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057380776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9564692,0.008074069,0.00000397541,0.02300422,0.0006468741,0.00036315617,0.00002072991,0.0000050477975,0.01141277],"genre_scores_gemma":[0.99600977,0.00037324135,0.00064829184,0.002362904,0.00028812862,0.000013619047,7.689476e-7,0.000009917123,0.00029333483],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841285,0.00043291284,0.0005017941,0.00021641246,0.0002858071,0.00015022414],"domain_scores_gemma":[0.9949944,0.0036447663,0.00064666313,0.00031416118,0.0003549088,0.00004510971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007100331,0.0001118185,0.00053353875,0.000021883376,0.00008689825,0.0000030943706,0.00011400892,0.0002995855,0.000031605938],"category_scores_gemma":[0.0038244762,0.000050066876,0.00013408782,0.0002231314,0.0007191769,0.000040460964,0.00013193092,0.0010331149,8.168064e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067972485,0.0018476282,0.93668073,0.00019508027,0.0006613418,0.000095598785,0.00010333062,0.0000056552526,0.0030569322,0.0070813433,0.016327633,0.027147466],"study_design_scores_gemma":[0.0020479856,0.001754565,0.9078776,0.00008961366,0.001553141,0.00039027713,0.00031293795,0.00000983795,0.00092772197,0.00005264974,0.084925465,0.00005815636],"about_ca_topic_score_codex":0.00020983692,"about_ca_topic_score_gemma":0.00041194574,"teacher_disagreement_score":0.06859784,"about_ca_system_score_codex":0.00004209414,"about_ca_system_score_gemma":0.0004131778,"threshold_uncertainty_score":0.45785314},"labels":[],"label_agreement":null},{"id":"W2068722130","doi":"10.1038/ncponc0909","title":"Should oncologists measure the mRNA and protein expression levels of ERCC1 and RRM1 in non-small-cell lung cancer?","year":2007,"lang":"en","type":"letter","venue":"Nature Clinical Practice Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"ERCC1; Messenger RNA; Cancer; Lung cancer; Biology; Cancer research; Medicine; Computational biology; Oncology; Gene; Genetics; DNA repair","score_opus":0.08356583590998254,"score_gpt":0.5005505703121375,"score_spread":0.4169847344021549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068722130","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022482783,0.033455413,0.000072817085,0.91632205,0.0013866205,0.004241572,0.000096427044,0.000031785974,0.021910554],"genre_scores_gemma":[0.17808317,0.003831916,0.010374049,0.79846996,0.0048323693,0.0005438798,0.000091652466,0.00011148995,0.0036615203],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963566,0.0008815193,0.0010896043,0.0007730846,0.00047394127,0.0004252348],"domain_scores_gemma":[0.99010396,0.007615214,0.0011701236,0.00049142836,0.0004733723,0.00014592132],"candidate_categories":["research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0025877957,0.0003807962,0.0012039795,0.0001685215,0.000111591,0.000021316384,0.00021032506,0.005272074,0.000057547655],"category_scores_gemma":[0.004798995,0.00023561643,0.0001487828,0.0002394781,0.0005018,0.00013538437,0.00016528042,0.010717836,0.0000021630467],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031194324,0.0019686678,0.010617189,0.0017936414,0.0009818624,0.0048546507,0.0011315438,0.0000027971337,0.0015362161,0.000036760273,0.8605212,0.113436066],"study_design_scores_gemma":[0.0064613316,0.0018570806,0.02301634,0.001034509,0.0023640029,0.00019322576,0.0003108757,0.000020318515,0.00024211519,0.000058625254,0.9641721,0.00026944152],"about_ca_topic_score_codex":0.00035337242,"about_ca_topic_score_gemma":0.0004459026,"teacher_disagreement_score":0.15560038,"about_ca_system_score_codex":0.000536016,"about_ca_system_score_gemma":0.0019199922,"threshold_uncertainty_score":0.9960193},"labels":[],"label_agreement":null},{"id":"W2076425341","doi":"10.1038/ncponc0383","title":"Are carboplatin and radiotherapy equally effective for the adjuvant treatment of stage I seminoma?","year":2006,"lang":"en","type":"article","venue":"Nature Clinical Practice Oncology","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Carboplatin; Seminoma; Stage (stratigraphy); Radiation therapy; Medicine; Adjuvant; Oncology; Adjuvant radiotherapy; Internal medicine; Cisplatin; Chemotherapy; Biology","score_opus":0.03585032015766051,"score_gpt":0.46867265963208055,"score_spread":0.43282233947442006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076425341","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42889085,0.5454102,0.0006604343,0.017183043,0.0008524922,0.0048217075,0.00016473139,0.00005725304,0.00195928],"genre_scores_gemma":[0.9901007,0.0010438318,0.0059736767,0.001730718,0.0005600992,0.00016398271,0.000026866042,0.000022538403,0.00037758754],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986638,0.0002735746,0.00042380966,0.00032128676,0.00014222565,0.00017529997],"domain_scores_gemma":[0.9822681,0.016453177,0.00070088735,0.000278088,0.0001979715,0.000101790385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004400065,0.00016439344,0.0006130443,0.000030017538,0.000075402815,0.000007765566,0.00004776985,0.00044277468,0.000017217411],"category_scores_gemma":[0.0040776534,0.000092458235,0.0002236794,0.00007293722,0.00019320202,0.000048893555,0.00001477325,0.000314125,0.0000016155091],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008982975,0.0077439086,0.12576607,0.00010606773,0.0017581778,0.00068684696,0.000094889714,0.000018974344,0.00026531922,0.0015352243,0.0016576853,0.85138386],"study_design_scores_gemma":[0.011874754,0.010093664,0.8446996,0.000032199037,0.002230139,0.0001094787,0.00020456033,0.00038021206,0.00008850644,0.00013955908,0.13005741,0.00008990944],"about_ca_topic_score_codex":0.00013278329,"about_ca_topic_score_gemma":0.00009328328,"teacher_disagreement_score":0.8512939,"about_ca_system_score_codex":0.00017916568,"about_ca_system_score_gemma":0.00020193882,"threshold_uncertainty_score":0.48816267},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W2081968604","doi":"10.1038/ncponc1180","title":"Intermittent androgen blockade should be regarded as standard therapy in prostate cancer","year":2008,"lang":"en","type":"article","venue":"Nature Clinical Practice Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Prostate cancer; Medicine; Androgen deprivation therapy; Androgen; Blockade; Oncology; Internal medicine; Prostate; Urology; Cancer; Hormone","score_opus":0.14144241773103078,"score_gpt":0.5351353390789122,"score_spread":0.3936929213478814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081968604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7600767,0.023958405,0.0000012102737,0.19415109,0.0010479033,0.0015515886,0.00003048938,0.000071799135,0.019110823],"genre_scores_gemma":[0.85767853,0.100191526,0.001122768,0.03293255,0.00082949456,0.0002576176,0.000053864696,0.000055410215,0.006878228],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966274,0.0006811027,0.00081034045,0.00067062926,0.00064261735,0.0005679485],"domain_scores_gemma":[0.9959889,0.0023511145,0.00030865707,0.00042998052,0.00056372676,0.0003575873],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0017019972,0.00025523937,0.00086099555,0.0001617493,0.00012889315,0.00001543104,0.0001950282,0.0009936704,0.00046533428],"category_scores_gemma":[0.0049449964,0.0001774442,0.00021570778,0.00037832165,0.0005247714,0.00020826221,0.00010978948,0.004101249,0.000049082133],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12959155,0.0061677154,0.25513664,0.00008418527,0.0014213403,0.028893797,0.0020527525,0.000005563238,0.0008455442,0.00021310496,0.12164733,0.45394048],"study_design_scores_gemma":[0.017991843,0.008989672,0.030895637,0.000085650834,0.00013400581,0.0010814244,0.0003620965,0.000014914636,0.0015880533,0.00016546794,0.9384875,0.00020373306],"about_ca_topic_score_codex":0.00019049604,"about_ca_topic_score_gemma":0.0001889485,"teacher_disagreement_score":0.8168402,"about_ca_system_score_codex":0.0007243598,"about_ca_system_score_gemma":0.0028814988,"threshold_uncertainty_score":0.9981963},"labels":[],"label_agreement":null},{"id":"W2088026063","doi":"10.1038/ncponc0022","title":"Are symptoms reliable as an indication for the necessity of bone scans in lung cancer metastases?","year":2004,"lang":"en","type":"article","venue":"Nature Clinical Practice Oncology","topic":"Medical Imaging and Pathology Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Lung cancer; Lung; Radiology; Cancer; Internal medicine","score_opus":0.05917526778022391,"score_gpt":0.5270221685789528,"score_spread":0.46784690079872887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088026063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.56764317,0.04086595,0.001348845,0.38247895,0.0025833952,0.0016747607,0.00005031803,0.00006549985,0.003289105],"genre_scores_gemma":[0.9505606,0.0021001098,0.0062936596,0.04012861,0.00058668596,0.00015416619,0.0000263795,0.000016107742,0.00013362689],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99791795,0.0004502545,0.00073923083,0.00038395982,0.00025044617,0.00025815956],"domain_scores_gemma":[0.9899748,0.00805889,0.0010295343,0.00037487413,0.00041350446,0.00014837604],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.004772395,0.00012909433,0.00070384843,0.000079704776,0.00012522985,0.0000053830163,0.0001474692,0.0007327065,0.00004089695],"category_scores_gemma":[0.047700476,0.00008290463,0.00011903262,0.00028151346,0.0006031287,0.00016679605,0.000057520967,0.002187113,0.0000053398594],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011715451,0.012833546,0.7696212,0.0008320779,0.0019107373,0.0012307976,0.0019989253,0.00029551002,0.00042643823,0.010214204,0.058384385,0.13053675],"study_design_scores_gemma":[0.016971292,0.0051361364,0.697147,0.00059390586,0.004476517,0.0004480178,0.0029941506,0.0004947387,0.00026002072,0.003545362,0.2676158,0.00031706368],"about_ca_topic_score_codex":0.00031839497,"about_ca_topic_score_gemma":0.00060244714,"teacher_disagreement_score":0.38291746,"about_ca_system_score_codex":0.0001562851,"about_ca_system_score_gemma":0.0007796641,"threshold_uncertainty_score":0.9603211},"labels":[],"label_agreement":null}]}